RxDoctor Payments DataLook up a doctor →

SIMBRINZA: payments to doctors

Payments that named SIMBRINZA as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$931K
Providers
5,435
Transactions
12,756
Average per transaction
$73

The per-transaction average — $73 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,435 providers the average total is $171, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Alcon$924,49899.3%
Alcon Research LLC$3,9200.4%
Novartis$2,5330.3%
← All drugs & devices